Miriam Isola

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

Salvatore De Vita, Luca Quartuccio, Miriam Isola et al. · Arthritis & Rheumatism · 2011 · 396 citations · Full text

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

Maddalena Peghin, Alvisa Palese, Margherita Venturini et al. · Clinical Microbiology and Infection · 2021 · 323 citations · Full text

Clinical Infectious Disease, Covid-19 Pandemic, Acute Infection +9

Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients

Tamara Ius, Miriam Isola, Riccardo Budai et al. · Journal of neurosurgery · 2012 · 288 citations · Full text

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Francesco Zaja, Michele Baccarani, Patrizio Mazza et al. · Blood · 2010 · 256 citations

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Salvatore De Vita, Franca Soldano, Miriam Isola et al. · Annals of the Rheumatic Diseases · 2011 · 153 citations · Full text